Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

AngioEvasion_001


ABSTRACT: We aim to identify the molecular mechanisms underlying LLC tumor evasion from endogenous angiogenesis inhibitor Endostatin in-vivo. Tumor cells were inoculated in C57/BL6 mice. Mice were treated with muFc-endostatin (20ᄉg/day) until the tumors evade therapy. Tumors were re-implanted in a new batch of mice for 4 consecutive in-vivo passages. Passage four (P4) endostatin-treated and control tumors were profiled. Significantly upregulated genes attributed to endostatin resistance were identified. Their gene expression levels were assessed by real-time PCR (Taqmanᆴ probe). Candidate genes were further functionally evaluated in-vivo using inhibitors.

ORGANISM(S): Mus musculus

SUBMITTER: Amir Abdollahi 

PROVIDER: E-MTAB-2529 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2009-04-25 | E-TABM-374 | biostudies-arrayexpress
2009-09-18 | E-TABM-561 | biostudies-arrayexpress
2009-04-25 | E-TABM-379 | biostudies-arrayexpress
2011-08-16 | E-TABM-1061 | biostudies-arrayexpress
2008-07-18 | E-TABM-481 | biostudies-arrayexpress
2008-06-30 | E-TABM-381 | biostudies-arrayexpress
2009-12-12 | E-TABM-595 | biostudies-arrayexpress
2017-07-05 | E-MEXP-1670 | biostudies-arrayexpress
2011-08-18 | E-TABM-1059 | biostudies-arrayexpress
2010-02-12 | E-MEXP-2090 | biostudies-arrayexpress